| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/06/2011 | WO2010086743A3 Codon-optimised hepatitis b virus core antigen |
| 01/06/2011 | WO2010083477A3 Broad spectrum vaccine against non-typhoidal salmonella |
| 01/06/2011 | WO2009122442A3 Mutants of streptokinase and their covalently modified forms |
| 01/06/2011 | US20110004949 Immunoglobulin 1 |
| 01/06/2011 | US20110004948 Immunoglobulin 2 |
| 01/06/2011 | US20110003972 Stabilizing polypeptides which have been exposed to urea |
| 01/06/2011 | US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer |
| 01/06/2011 | US20110003382 Use of corticosterone for increasing egg antibody |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110003319 Transgenic Trasnchromosomal Rodents for Making Human Antibodies |
| 01/06/2011 | US20110003009 Process for obtaining a rabbit skin comprising biological active substances |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002980 Vaccines using nucleic acid-lipid complexes |
| 01/06/2011 | US20110002978 Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
| 01/06/2011 | US20110002964 Methods for cancer treatment using stem cells |
| 01/06/2011 | US20110002963 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/06/2011 | US20110002962 Immunogenic PcpA Polypeptides and Uses Thereof |
| 01/06/2011 | US20110002961 Interleukin 12 paracrine gene delivery enhanced CTL immunotherapy |
| 01/06/2011 | US20110002960 Influenza hemagglutinin and neuraminidase variants |
| 01/06/2011 | US20110002959 Vaccine Production For Pathogenic Bird Viral Diseases |
| 01/06/2011 | US20110002958 Alphavirus Vectors for Respiratory Pathogen Vaccines |
| 01/06/2011 | US20110002957 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/06/2011 | US20110002955 Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 01/06/2011 | US20110002954 Rhoc-based immunotherapy |
| 01/06/2011 | US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002951 Modified Leukotoxin Gene and Protein |
| 01/06/2011 | US20110002950 Pig edema disease vaccine |
| 01/06/2011 | US20110002949 Vaccine for the treatment of alzheimer's disease |
| 01/06/2011 | US20110002948 Identification of a nucleic acid molecule |
| 01/06/2011 | US20110002947 Leptomycin derivatives |
| 01/06/2011 | US20110002946 Immunostimulatory Combinations |
| 01/06/2011 | US20110002945 Use of immunoglobulin heavy and light chains or fragments thereof to bind to aggregated amyloidogenic proteins |
| 01/06/2011 | US20110002944 Compositions and Methods to Promote Neural Cell Growth |
| 01/06/2011 | US20110002943 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 01/06/2011 | US20110002942 Engineered Anti-IL-23 Antibodies |
| 01/06/2011 | US20110002941 Antibodies that Specifically Bind Hedgehog-Derived Polypeptides |
| 01/06/2011 | US20110002940 Pathways involved in arteriogenesis and uses thereof |
| 01/06/2011 | US20110002939 monoclonal antibody and a method thereof |
| 01/06/2011 | US20110002938 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3 |
| 01/06/2011 | US20110002937 Method of making hybrid cells that express useful antibodies |
| 01/06/2011 | US20110002936 Anti-IL-6/IL-6R Antibodies and Methods of Use Thereof |
| 01/06/2011 | US20110002935 Antibody purification |
| 01/06/2011 | US20110002934 Uses of anti-cd40 antibodies |
| 01/06/2011 | US20110002933 Dr4 antibodies and uses thereof |
| 01/06/2011 | US20110002932 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
| 01/06/2011 | US20110002931 Bispecific antibodies that bind to complement proteins |
| 01/06/2011 | US20110002930 Activated T Cells |
| 01/06/2011 | US20110002929 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 01/06/2011 | US20110002928 Uses of Mammalian Cytokine; Related Reagents |
| 01/06/2011 | US20110002927 Antigen-binding polypeptides against cartilage degeneration |
| 01/06/2011 | US20110002926 Hepatitis c virus antibodies |
| 01/06/2011 | US20110002925 Use of Anti-IL-20 Antibody for Treating Rheumatoid Arthritis and Osteoporosis |
| 01/06/2011 | US20110002924 Tweak receptor agonists as anti-angiogenic agents |
| 01/06/2011 | US20110002923 Methods of inhibiting tumor growth using ttk antagonists |
| 01/06/2011 | US20110002922 Cell growth inhibitors containing anti-glypican 3 antibody |
| 01/06/2011 | US20110002921 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002920 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002919 Antagonists of neuropilin receptor function and use thereof |
| 01/06/2011 | US20110002918 Methods of treating diseased tissue |
| 01/06/2011 | US20110002917 Antibody constant domain regions and uses thereof |
| 01/06/2011 | US20110002916 Plasmodium falciparum antigens and their vaccine and diagnostic applications |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002913 Use of interleukin-4 antagonists and compositions thereof |
| 01/06/2011 | US20110002912 Composition |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002887 Combinations of antibodies selective for dr5 and other therapeutic agents |
| 01/06/2011 | US20110002884 Therapeutic compounds |
| 01/06/2011 | US20110002881 Treatment and prophylaxis |
| 01/06/2011 | US20110002879 Combinations of Pyrazole Kinase Inhibitors |
| 01/06/2011 | US20110002851 Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases |
| 01/06/2011 | US20110002846 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neural and glial tumors of the brain |
| 01/06/2011 | US20110002845 Methods of treating, diagnosing or detecting fgf21-associated disorders |
| 01/06/2011 | US20110000480 Administration of interferon for prophylaxis against or treatment of pathogenic infection |
| 01/06/2011 | CA2767105A1 Methods of stimulating liver regeneration |
| 01/06/2011 | CA2767063A1 Novel therapeutic and diagnostic means |
| 01/06/2011 | CA2766899A1 Compositions and methods for diagnosing and/or treating influenza infection |
| 01/06/2011 | CA2766833A1 Exosome-based treatment of cancer |
| 01/06/2011 | CA2766805A1 Hyr1 as a target for active and passive immunization against candida |
| 01/06/2011 | CA2766770A1 Novel antibodies and their uses in therapeutic and diagnostic methods |
| 01/06/2011 | CA2766641A1 Polypeptides and method of treatment |
| 01/06/2011 | CA2766537A1 Multimeric peptide conjugates and uses thereof |
| 01/05/2011 | EP2270225A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270224A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270223A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270222A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270221A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270220A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270219A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270218A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270217A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270216A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270215A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270214A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270213A2 Method for diagnosing non-small cell lung cancers |
| 01/05/2011 | EP2270212A2 Method for diagnosing non-small cell lung cancers |